Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Stoppa

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
European Cytokine Network|February 12, 1998
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantationN Vey, P Viens, C Fossat, et al.
Cytotherapy|June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMTM Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation|February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myelomaH de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation|November 3, 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicityS Garciaz, D Coso, J-M Schiano de Collela, et al.
British Journal of Cancer|March 1, 1992
Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantationB Richard, M C Launay-Iliadis, A Iliadis, et al.
Bone Marrow Transplantation|September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationM Mohty, C Faucher, N Vey, et al.
Bone Marrow Transplantation|January 31, 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantationJ El-Cheikh, C Faucher, S Fürst, et al.
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Bone Marrow Transplantation|September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignanciesN Vey, B De Prijck, C Faucher, et al.
Leukemia|June 27, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparisonM Mohty, H de Lavallade, J El-Cheikh, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
European Cytokine Network|February 12, 1998
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantationN Vey, P Viens, C Fossat, et al.
Cytotherapy|June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMTM Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation|February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myelomaH de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation|November 3, 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicityS Garciaz, D Coso, J-M Schiano de Collela, et al.
British Journal of Cancer|March 1, 1992
Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantationB Richard, M C Launay-Iliadis, A Iliadis, et al.
Bone Marrow Transplantation|September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationM Mohty, C Faucher, N Vey, et al.
Bone Marrow Transplantation|January 31, 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantationJ El-Cheikh, C Faucher, S Fürst, et al.
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Bone Marrow Transplantation|September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignanciesN Vey, B De Prijck, C Faucher, et al.
Leukemia|June 27, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparisonM Mohty, H de Lavallade, J El-Cheikh, et al.
Pageof 14